Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 3/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.36 |
| ▸ | DHODH | Q02127 | 4/20 | 0.35 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17403774 | 0.89 | DHODH (0.40) | CYP2C9ADORA2AALDH1A1ADORA1DHODH | |
| SCHEMBL17034902 | 0.81 | MAPT (0.39) | CYP2C9ADORA2AMAPTALDH1A1DHODH | |
| SCHEMBL17403769 | 0.80 | DHODH (0.45) | ADORA2AMAPTALDH1A1DHODHNUDT1 | |
| SCHEMBL25786104 | 0.79 | MEN1 (0.41) | CYP2C9ADORA2AMAPTALDH1A1ADORA1 | |
| SCHEMBL18346972 | 0.79 | TOP1 (0.36) | CYP2C9ADORA2AMAPTALDH1A1ADORA1 | |
| SCHEMBL18200342 | 0.79 | MAPT (0.37) | ADORA2AMAPTALDH1A1DHODHPDE10A | |
| SCHEMBL17300232 | 0.78 | DHODH (0.37) | ADORA2ADHODHNUDT1PDE10ALMNA | |
| SCHEMBL18200769 | 0.78 | ADORA2A (0.34) | CYP2C9ADORA2AMAPTALDH1A1ADORA1 | |
| SCHEMBL18085294 | 0.78 | MAPT (0.36) | CYP2C9MAPTALDH1A1ESR1ESR2 | |
| SCHEMBL732365 | 0.78 | ADORA2A (0.46) | ADORA2AALDH1A1ESR1ESR2ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230284524-A1 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-09-07 | — | — | US | disclosed |
| US-20230284524-A1 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-09-07 | — | — | US | disclosed |
| US-20220190296-A1 | LIGHT-EMITTING DEVICE AND AN ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-06-16 | — | — | US | disclosed |
| US-20220173331-A1 | LIGHT-EMITTING DEVICE AND AN ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230284524-A1 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | EML4, SLC1A2, EMD | CYP2C9 882/4885ADORA2A 3293/4885MAPT 2628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.